<DOC>
	<DOCNO>NCT02815761</DOCNO>
	<brief_summary>Chronic obstructive pulmonary disease ( COPD ) common disease worldwide high burden healthcare resource . The prevalence COPD vary 11.4 26.1 % accord recent multi-city population study use spirometry . In Hong Kong ( HK ) , prevalence rate COPD elderly population age ≥60 year 25.9 % 12.4 % base spirometric definition force expiratory volume 1 ( FEV1 ) /forced vital capacity ( FVC ) ratio &lt; 70 % low limit normal FEV1/FVC respectively . In 2005 , crude mortality rate COPD 29.1/100 000 , crude hospitalization rate 193/100,000 HK . In HK , COPD rank second respiratory cause hospitalization . In 75 year old , hospitalization rate COPD high 2,225/100,000 . The economic burden COPD society enormous . Previous study give information overall morbidity , mortality prevalence COPD HK . One study compare management COPD patient HK country find COPD patient HK under-treated . No large scale study look detail COPD patient HK , like co-morbidities treated factor affect readmission patient . Large prospective study incorporate potentially relevant variable require refine prediction important outcome AECOPD thus inform clinical decision making , example escalation care , facilitate discharge provision palliative care .</brief_summary>
	<brief_title>A Prospective Study Readmission Mortality COPD Patients</brief_title>
	<detailed_description>Aim study The aim study assess factor related readmission mortality COPD patient Hong Kong . Method This prospective observational study patient . Patients admit participate hospital acute exacerbation COPD ( AECOPD ) recruit . AECOPD define occur patient background COPD11 , FEV1/FVC ratio &lt; 70 % , present least two major symptom ( increased dyspnea , increase sputum purulence , increase sputum volume ) , one major one minor symptom ( nasal discharge/congestion , wheeze , sore throat , cough ) least 2 consecutive day . Written inform consent obtain subject . Inclusion criterion : 1 . Subjects diagnosis COPD accord Global Initiative chronic Obstructive Lung Disease ( GOLD ) Guideline16 previous spirometry show FEV1/FVC ratio &lt; 0.70 AECOPD recruit study . 2 . Age ≥40 year Exclusion criterion : 1 . Subjects diagnose asthma , bronchiectasis chronic lung disease apart COPD exclude 2 . Patients history lung resection 4 . Those unable give consent Baseline assessments 1 . Baseline assessment perform 6-8 week AECOPD patient stable state . 2 . Demographic data include age , sex , body weight , height , smoke history , social history medication usage , co-morbidities home oxygen non-invasive positive pressure ventilation ( NPPV ) usage collect . Number hospitalization accident emergency department attendance past 12 month record . Any history intubation acute NPPV usage note also . 3 . American Thoracic Society ( ATS ) respiratory questionnaire17 ask . 4 . Spirometry perform use MICROLAB 3300 spirometer ( Micro Medical , Kent , UK ) sit position , accord ATS/European Respiratory Society ( ERS ) standards.18 Both pre- post-bronchodilator ( 20 min inhale 400 mg salbultamol [ Ventolin ; GlaxoSmithKline , E´ vreux , France ] 500 mL spacer ) test perform . The updated predict spirometric value Hong Kong Chinese use . 5 . Six min walk test perform accord ATS guideline . 6 . Modified Medical Research Council dyspnoea scale ( MMRC ) 21 assess . 7 . St George 's Respiratory Questionnaire ( SGRQ ) 22 medical outcome short form 36 questionnaire ( SF-36 ) 23 administered subject . 8 . Depression score 9 . Blood save inflammatory marker analyse Subsequent assessment : Subjects reassess every 12 month repeat spirometry , 6 minute walk test , MMRC , SGRQ SF-36 score total 3 year . All hospitalization , schedule unscheduled clinic visit subsequent 36 month baseline assessment record ask patient verification computer medical record . Any mortality ( cause ) also record . Sample size : This prospective observational study primary aim ass factor related readmission mortality COPD patient Hong Kong . We believe sample size 800 would able give u meaningful data . Data analysis : Data analyze Statistical Package Social Science ( SPSS ) Statistical software Window , Version 17.0 ( SPSS Inc , IL , USA ) . Descriptive statistic use data present mean ( SD ) median ( IQR ) appropriate . Chi-square test , t-test , Mann-Whitney U test use compare clinical parameter COPD patient different disease severity appropriate . A p value &lt; 0.05 consider significant .</detailed_description>
	<criteria>1 . Subjects diagnosis COPD accord Global Initiative chronic Obstructive Lung Disease ( GOLD ) Guideline16 previous spirometry show FEV1/FVC ratio &lt; 0.70 AECOPD recruit study . 2 . Age ≥40 year 1 . Subjects diagnose asthma , bronchiectasis chronic lung disease apart COPD exclude 2 . Patients history lung resection 4 . Those unable give consent</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>